PIP2 (phosphatidylinositol 4,5-bisphosphate) inhibitors constitute a notable chemical class with profound implications in cellular signaling and biochemical processes. These molecules are characterized by their ability to modulate the levels of PIP2, a crucial lipid present in the cell membrane. PIP2 serves as a fundamental precursor for various secondary messengers, such as inositol trisphosphate (IP3) and diacylglycerol (DAG), which subsequently mediate a wide array of intracellular signaling cascades. PIP2 inhibitors exert their effects by disrupting the equilibrium between PIP2 synthesis and degradation, leading to altered downstream signaling pathways.
Structurally, PIP2 inhibitors encompass diverse chemical moieties that interact with distinct regions of the lipid bilayer. This interaction can be attributed to the amphipathic nature of PIP2 inhibitors, allowing them to associate with the hydrophobic lipid tails while simultaneously interacting with the polar head groups. As a result, PIP2 inhibitors impede the accessibility of key enzymes, such as phospholipase C (PLC), to their substrate PIP2, thereby attenuating the generation of secondary messengers like IP3 and DAG. Additionally, some PIP2 inhibitors possess cationic or anionic properties, which facilitate electrostatic interactions with the negatively charged phosphate groups on the PIP2 molecule. The significance of PIP2 inhibitors extends to their role in modulating cellular processes ranging from cytoskeletal rearrangements to ion channel regulation. By perturbing PIP2 levels, these inhibitors influence the activities of proteins involved in cytoskeleton dynamics, membrane trafficking, and ion channel gating. This comprehensive modulation of intracellular pathways underscores the crucial role of PIP2 inhibitors as invaluable tools for investigating the intricacies of cellular signaling and molecular interactions. In research settings, PIP2 inhibitors have illuminated the complex web of interactions that govern cellular responses, offering insights into the intricacies of membrane-associated signaling events.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A potent and irreversible inhibitor of PIP2 synthesis by inhibiting phosphoinositide 3-kinase (PI3K) enzymes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A reversible inhibitor of PI3K, which leads to decreased PIP2 levels and affects various cellular processes like cell growth and survival. | ||||||
AS-252424 | 900515-16-4 | sc-202961 sc-202961A | 1 mg 5 mg | $41.00 $155.00 | ||
This small molecule inhibits PIP2 signaling by affecting phosphoinositide-specific phospholipase C (PI-PLC) activity. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $189.00 | 4 | |
An agent targeting PI3Kδ, leading to PIP2 reduction and impacting signaling pathways in certain types of lymphomas. | ||||||
Apilimod | 541550-19-0 | sc-480051 sc-480051A | 100 mg 1 g | $420.00 $2600.00 | 5 | |
An inhibitor of phosphatidylinositol 3-kinase (PIKfyve), which regulates endosome trafficking and vesicle transport by modulating PIP2 levels. | ||||||
IC-87114 | 371242-69-2 | sc-364509 sc-364509A | 5 mg 50 mg | $140.00 $1060.00 | 1 | |
A selective inhibitor of PI3Kδ, involved in immune cell signaling, leading to reduced PIP2 levels and immunomodulation. | ||||||
PI 3-Kβ Inhibitor VI, TGX-221 | 663619-89-4 | sc-203190 | 1 mg | $437.00 | ||
This compound inhibits PI3Kβ isoform, influencing PIP2-dependent signaling pathways associated with cell motility and growth. | ||||||
YM201636 | 371942-69-7 | sc-204193 | 5 mg | $213.00 | 6 | |
A PI3Kα-selective inhibitor that interferes with PIP2-mediated signaling pathways implicated in cancer cell proliferation. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $173.00 $230.00 $275.00 $332.00 | 9 | |
An pan-PI3K inhibitor that reduces PIP2 levels, showing promise in research models for various solid tumors. | ||||||